You have searched for "Russian Direct Investment Fund"
Showing 1-10 of 126
KUALA LUMPUR: Stocks that saw recent news flow and could be the target of investor trading on Tuesday include MGB, Comintel, Paramount, UCrest, BSL, Hubline, FoundPac and Teladan Setia, said JF Apex Research.
Philippine authorities announced that the Food and Drug Administration (FDA) has approved the emergency use of Russia's Sputnik Light Covid-19 vaccine, making it the first country in Southeast Asia to approve this single-dose vaccine.
TWO Vietnamese companies have reached a technology transfer agreement with Japanese drugmaker Shionogi to produce Covid-19 vaccines.
HANOI (AFP): Two Vietnamese companies have reached a technology transfer agreement with Japanese drugmaker Shionogi to produce Covid-19 vaccines, state media said Tuesday (July 27).
Prime Minister Phạm Minh Chinh has directed the development and production of home-grown vaccines to move faster, but has said their safety and efficacy must be ensured.
Russia announced that a batch of its Sputnik V coronavirus vaccine was produced for the first time in Vietnam, which is battling a new wave of Covid-19 infections.
HANOI (Vietnam News/ANN): Vietnam has manufactured the first test batch of Covid-19 vaccine Sputnik V, according to an announcement by Russia’s sovereign wealth fund Russian Direct Investment Fund (RDIF) and Vietnamese pharmaceutical company VABIOTECH released on Wednesday (July 21).
VLADIMIR, Russia (Reuters) -Alexander tried three times over 10 days to get his first dose of Russia's Sputnik V coronavirus vaccine in his home town of Vladimir. Twice, supplies ran out as he was standing in the queue.
Vietnam's Covid-19 cases soaring; reports 2,301 new cases, 34,500 in total as govt approves 40 million Sputnik V-doses deal
Vietnam reported 2,301 new Covid-19 infections on Tuesday, including 2,296 locally transmitted and five imported, bringing the total tally to 34,500, according to the country's Ministry of Health.
PARIS (Reuters) - The developers of Russia’s Sputnik V coronavirus vaccine have repeatedly failed to provide data that regulators deem to be standard requirements of the drug approval process, according to five people with knowledge of European efforts to assess the drug, providing new insight into the country’s struggle to win foreign acceptance of its product.